Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
about
Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling dataWNT7a induces E-cadherin in lung cancer cellsBeta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletionTranscriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancerSOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.Interactions between β-catenin and the HSlo potassium channel regulates HSlo surface expressionKnockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium.Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma.Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma.Altered protease-activated receptor-1 expression and signaling in a malignant pleural mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene.Identification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing.Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancerPathogenesis of malignant pleural mesothelioma.Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practiceThe E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis.Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancerCancer stem cells: progress and challenges in lung cancer.Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma.Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.High-fidelity target sequencing of individual molecules identified using barcode sequences: de novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patientsMicroenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma.Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report.Antagonism between Hedgehog and Wnt signaling pathways regulates tumorigenicity.Resistance mechanisms to targeted therapies in ROS1+ and ALK+ non-small cell lung cancer.Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.Comprehensive review of fetal adenocarcinoma of the lung
P2860
Q21266587-F2F13F75-5438-41C5-A57D-7DD4EF1F8583Q24317695-0D0593BA-F8CD-4181-88FB-548891FECD9BQ24322289-8A653A06-3EC7-4FD2-BE6D-CF50E95927FBQ28260824-5C81E350-1E5B-43D0-B93C-680760244989Q33771090-3803D3B0-FFAB-4CA9-AB71-44438D3BB347Q34109981-652CE227-E6C7-4DA5-B50A-FACD5A88203CQ34701196-D1E0BED4-40E3-4331-87B4-CC7345BAF6C2Q34876177-DB0B6871-9AC2-46F7-85A7-14FB90B1209DQ34976628-F906FC08-5E8B-4B03-9547-B2AF583D532BQ35076075-99F9F09A-8088-4ACA-9189-EEFB76974AD7Q35386878-1E22868C-9B77-405F-B5E8-743C6463D552Q35811159-B0A21020-24D1-45DB-94A3-B42128DBFFBBQ35853581-2E3CBE5D-49CE-4B1A-A737-0A28AC548BE9Q36021953-86DBAB84-0821-49DB-832E-D9E741C25C78Q36029841-202A8E2D-9593-4C8D-A6C7-E5953B318A8AQ36383418-CF57E2DF-D551-4C5B-A055-4B3A3BC2EB99Q36429579-54544398-14F8-4111-9FE2-54B2FAC3C9E9Q36536565-DF83934F-B7D8-47CD-8C81-2AD0DDA114ACQ38881450-8205729D-5235-4403-9F78-C283B6D610D7Q39997522-3D6C8EA5-053E-4697-A8AC-94DD9D55B87BQ40035147-DD93E890-CDA6-45EB-8C00-EE24D182ACEEQ40176023-533419ED-B83A-4178-97E9-89CEA7A9F773Q41766783-801C8A62-B9F8-4C25-9909-67825E794F0CQ42098747-56EBED88-7935-49C2-B75D-71305CABA106Q42524460-7C402591-615C-43AE-A7C2-A3015059BAA6Q42548512-9D176478-9250-4728-9515-CAB93D814FA6Q49287962-38EC1FEE-C7B2-4849-BA68-7C8AF4456369Q49387038-8E7E91C2-1BE9-441D-8662-D65E6AD4F0B4Q52720230-D5C40F3C-5DFB-4E6C-BE45-00F681513EA8Q53326540-FE0D9C64-6637-405E-A6FD-75E56E0FF767Q57640146-4879E1C4-195F-4503-8AF4-11369F096EDF
P2860
Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Genetic alteration of the beta ...... ew 3p21.3 homozygous deletion.
@en
type
label
Genetic alteration of the beta ...... ew 3p21.3 homozygous deletion.
@en
prefLabel
Genetic alteration of the beta ...... ew 3p21.3 homozygous deletion.
@en
P2093
P2860
P356
P1433
P1476
Genetic alteration of the beta ...... ew 3p21.3 homozygous deletion.
@en
P2093
Hasegawa Y
Imaizumi M
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204557
P407
P577
2001-07-01T00:00:00Z
P5875
P6179
1022217223